Hims & Hers, a leading personalized healthcare company, has announced impressive results, showcasing record revenue growth and expanding its customer base. The company’s platform is gaining traction as customers seek tailored treatment plans for their specific health needs.
Key highlights from the latest results include:
– Revenue grew 73% to $545M, exceeding expectations
– Adjusted EBITDA more than doubled, demonstrating operational efficiency
– Subscriber base expanded by 31%, with over 1.5 million customers utilizing personalized treatment plans
The company’s strategic investments in new capabilities and talent expansion are driving growth and innovation. By adding lab testing and strengthening its provider network, Hims & Hers is poised to further accelerate its expansion.
CEO Abby Reisinger-Moley commented on the company’s progress: “Our model is working, and we’re meeting the moment. We’re committed to delivering high-quality, personalized care to millions of people worldwide.”
With a strong track record of success and expanding offerings, Hims & Hers is well-positioned for continued growth in the rapidly evolving healthcare industry.
Note: The provided text has been simplified and restructured for easier reading while retaining essential information.
Source: https://news.hims.com/newsroom/investing-in-the-future-of-healthcare